Neurocognitive Effects of Bilateral STN Versus GPi DBS in Parkinson's Disease Patients With MCI

Stopped early · Not applicable

Conditions studied: Parkinson's Disease, Mild Cognitive Impairment, Dementia

In brief

Purpose: This is a prospective single-center, randomized, patient and evaluator-blind clinical trial to compare the neurocognitive outcomes of globus pallidus interna (GPi) versus subthalamic nucleus (STN) deep brain stimulation (DBS) in Parkinson's disease (PD) patients with mild cognitive impairment (MCI).

Key facts

Study ID

NCT01870518

Run by

St. Joseph's Hospital and Medical Center, Phoenix

People needed

13

Starts

2013-04-01

Expected to finish

2016-02-01

Last updated by the study team

2016-02-10

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• clinical diagnosis of idiopathic Parkinson's disease
• deemed an appropriate candidate for DBS surgery
• Montreal Cognitive Assessment (MoCA) score < 25
• Neuropsychological testing with the diagnosis of Mild Cognitive Impairment

You may not qualify if…

• no diagnosis of Parkinson's disease
• not appropriate for DBS surgery

Where it is running

• Barrow Neurological Institute / St. Joseph's Hospital & Medical Center — Phoenix, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.